Clinical Trials Browser

Maximum Tolerated Dose × Genitourinary × 90 days × Clear all

NCT03663218 2026-03-18

PREPARE SBRT

Phase NA Active not recruiting

16 enrolled 9 charts

Prostatic Neoplasms